Annual SG&A:
$50.83M-$3.11M(-5.76%)Summary
- As of today, CNTA annual SG&A is $50.83 million, with the most recent change of -$3.11 million (-5.76%) on December 31, 2024.
- During the last 3 years, CNTA annual SG&A has risen by +$7.83 million (+18.20%).
- CNTA annual SG&A is now -7.86% below its all-time high of $55.17 million, reached on December 31, 2022.
Performance
CNTA SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$12.38M(-100.00%)Summary
- As of today, CNTA quarterly SG&A is $0.00, with the most recent change of -$12.38 million (-100.00%) on June 1, 2025.
- Over the past year, CNTA quarterly SG&A has dropped by -$11.18 million (-100.00%).
- CNTA quarterly SG&A is now -100.00% below its all-time high of $16.20 million, reached on March 31, 2023.
Performance
CNTA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$3.95B-$230.37M(-6.20%)Summary
- As of today, CNTA TTM SG&A is -$3.95 billion, with the most recent change of -$230.37 million (-6.20%) on June 1, 2025.
- Over the past year, CNTA TTM SG&A has dropped by -$4.00 billion (-8156.67%).
- CNTA TTM SG&A is now -1522.08% below its all-time high of -$243.27 million.
Performance
CNTA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
CNTA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -5.8% | -100.0% | -8156.7% |
| 3Y3 Years | +18.2% | -100.0% | -7360.6% |
| 5Y5 Years | +6334.5% | -100.0% | -10000.0% |
CNTA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -7.9% | +18.2% | -100.0% | at low | -108.9% | at low |
| 5Y | 5-Year | -7.9% | +1506.9% | -100.0% | at low | -1522.1% | at low |
| All-Time | All-Time | -7.9% | +6334.5% | -100.0% | at low | -1522.1% | at low |
CNTA Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $25.01M(-30.9%) |
| Mar 2025 | - | $12.38M(>+9900.0%) | $36.19M(-2.8%) |
| Dec 2024 | $50.83M(-5.8%) | $0.00(-100.0%) | $37.24M(-25.0%) |
| Sep 2024 | - | $12.63M(+13.0%) | $49.66M(+1.4%) |
| Jun 2024 | - | $11.18M(-16.8%) | $48.98M(-4.3%) |
| Mar 2024 | - | $13.43M(+8.1%) | $51.19M(-5.1%) |
| Dec 2023 | $53.94M(-2.2%) | $12.42M(+4.0%) | $53.96M(-2.6%) |
| Sep 2023 | - | $11.95M(-10.8%) | $55.41M(-0.4%) |
| Jun 2023 | - | $13.39M(-17.3%) | $55.64M(-2.2%) |
| Mar 2023 | - | $16.20M(+16.8%) | $56.88M(+3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $55.17M(+28.3%) | $13.87M(+13.9%) | $54.99M(+1.6%) |
| Sep 2022 | - | $12.18M(-16.8%) | $54.12M(-0.4%) |
| Jun 2022 | - | $14.63M(+2.3%) | $54.35M(+5.5%) |
| Mar 2022 | - | $14.30M(+10.0%) | $51.53M(+13.3%) |
| Dec 2021 | $43.00M(+1259.4%) | $13.00M(+4.8%) | $45.47M(-6.1%) |
| Sep 2021 | - | $12.41M(+5.0%) | $48.45M(+34.4%) |
| Jun 2021 | - | $11.82M(+43.4%) | $36.04M(+48.8%) |
| Mar 2021 | - | $8.24M(-48.4%) | $24.22M(+51.6%) |
| Dec 2020 | $3.16M(+300.4%) | - | - |
| Dec 2020 | - | $15.98M | $15.98M |
| Dec 2019 | $790.00K | - | - |
FAQ
- What is Centessa Pharmaceuticals plc annual SG&A?
- What is the all-time high annual SG&A for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc annual SG&A year-on-year change?
- What is Centessa Pharmaceuticals plc quarterly SG&A?
- What is the all-time high quarterly SG&A for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc quarterly SG&A year-on-year change?
- What is Centessa Pharmaceuticals plc TTM SG&A?
- What is the all-time high TTM SG&A for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc TTM SG&A year-on-year change?
What is Centessa Pharmaceuticals plc annual SG&A?
The current annual SG&A of CNTA is $50.83M
What is the all-time high annual SG&A for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high annual SG&A is $55.17M
What is Centessa Pharmaceuticals plc annual SG&A year-on-year change?
Over the past year, CNTA annual SG&A has changed by -$3.11M (-5.76%)
What is Centessa Pharmaceuticals plc quarterly SG&A?
The current quarterly SG&A of CNTA is $0.00
What is the all-time high quarterly SG&A for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high quarterly SG&A is $16.20M
What is Centessa Pharmaceuticals plc quarterly SG&A year-on-year change?
Over the past year, CNTA quarterly SG&A has changed by -$11.18M (-100.00%)
What is Centessa Pharmaceuticals plc TTM SG&A?
The current TTM SG&A of CNTA is -$3.95B
What is the all-time high TTM SG&A for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high TTM SG&A is -$243.27M
What is Centessa Pharmaceuticals plc TTM SG&A year-on-year change?
Over the past year, CNTA TTM SG&A has changed by -$4.00B (-8156.67%)